LifeStance Health Group Inc. recently held their second quarter 2025 earnings conference call, where the management team, including CEO Dave Bourdon, announced strong financial results. The company achieved double-digit organic revenue growth and 10% adjusted EBITDA margins, prompting an increase in full-year guidance for adjusted EBITDA. LifeStance also reported a record free cash flow of $57 million, reflecting the resilience and differentiation of their patient care model, which offers both in-person and virtual care. The full speech/interview is available on their Investor Relations website. For more details, visit investor.lifestance.com.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.